PHA-793887 T2113
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
PHA-793887 has been used in trials studying the treatment of Advanced/Metastatic Solid Tumors.
CAS nr:
718630-59-2
Purity:
98%
Molecular Weight:
361,48
SMILES:
CN1CCC(C(=O)N2C(C)(C)c3[nH]nc(NC(=O)CC(C)C)c3C2)CC1
Formula:
C19H31N5O2
Pathway:
Cell Cycle/Checkpoint,Apoptosis
Target:
CDK,Apoptosis
